Innovations in group‐based psilocybin‐assisted therapy of major depression in patients with cancer
Johannes Thrul, Zofia Kozak, Michael A. Carducci, Albert Garcia‐romeu, David B. Yaden
Cancer December 18, 2023 DOI: 10.1002/cncr.35127 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Editorial Peer reviewed |
|---|---|
| Topics | Psilocybin Depression |
| Keywords | Cancer Depression economics Mood Distress Psychotherapist Intervention counseling Oncology Clinical psychology Hallucinogen |
| Citations | 5 |
| Key points | Argues that group-based psilocybin-assisted intervention may be a novel therapeutic approach for treating depression in cancer patients. |
Abstract
Several recent studies have investigated psilocybin as a novel therapeutic compound for the treatment of existential distress in patients with cancer, demonstrating persistent, positive effects on mood. This editorial discusses two articles in the current issue of Cancer that report findings of a group‐based psilocybin‐assisted intervention for treatment of depression in patients diagnosed with cancer.